Knee Cartilage Replacement Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Knee Cartilage Replacement Market to 2027 - Global Analysis and Forecasts By Treatment Modality (Cell Based Approaches and Non-Cell Based Approaches), Application (Hyaline Cartilage and Fibrocartilage) and Geography

Report Code: TIPMD00002565 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Cartilage is a soft and rubbery material present in the bone joint and is involved in preventing friction between the bones by acting as a shock absorber in the joint. Damage to cartilage restricts the normal movement of knee causing pain and most often occurs after a traumatic and twisting injury to the knee. If left untreated, it may require knee replacement surgery. Knee cartilage repair has been beneficial for conditions such as mal-unions, delayed unions, and slow healing wounds. Advances in knee cartilage repair products have bolstered the growth of this industry.

The knee cartilage replacement market is anticipated to grow with a significant rate in the coming years, owing to factors such as rising incidences of orthopedic diseases, surge in sports injuries, growing geriatric population and rising prevalence of obesity. Moreover, technological advancements in cartilage regeneration are offering the opportunities for the knee cartilage replacement market growth across the globe.

The "Global Knee Cartilage Replacement Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global knee cartilage replacement market trend. The report aims to provide an overview of global knee cartilage replacement market with detailed market segmentation by modalities and application. The global knee cartilage replacement market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global knee cartilage replacement market is segmented on the basis of on treatment modalities and application. The treatment modalities segment includes, cell based approaches and non-cell based approaches. The cell based approaches are further sub-segmented into chondrocyte transplantation, growth factor technology. The non-cell based approaches are further sub-segmented into tissue scaffolds, and cell-free composites. Based on application, the knee cartilage replacement market is segmented as, hyaline cartilage and fibrocartilage.

The knee cartilage replacement market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global knee cartilage replacement market based on treatment modalities, and application. It also provides market size and forecast till 2027 for overall knee cartilage replacement market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The knee cartilage replacement market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to hold the largest share in the knee cartilage replacement market, due to increasing prevalence of musculoskeletal diseases, presence of target population, and changing lifestyle of individuals in the U.S. and Canada. Asia Pacific is one of the most lucrative markets for the growth of knee cartilage repair market as the region is developing at a faster pace, owing to the increasing number of patient population base, rising demand for elder care and treatment for age-related conditions that would also fuel the growth of the market in the coming few years.

The knee cartilage replacement market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The knee cartilage replacement market report also includes the profiles of key knee cartilage replacement companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Anika Therapeutics, Zimmer Biomet, BioTissue, DePuy Synthes, Genzyme Corporation, CellGenix GmbH, EMD Serono Inc, Sanofi, Osiris and TiGenix among others.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. KNEE CARTILAGE REPLACEMENT MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Knee Cartilage Replacement Market - By Treatment Modality
3.2.2. Knee Cartilage Replacement Market - By Application
3.2.3. Knee Cartilage Replacement Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. KNEE CARTILAGE REPLACEMENT MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. KNEE CARTILAGE REPLACEMENT MARKET - GLOBAL ANALYSIS
5.1. GLOBAL KNEE CARTILAGE REPLACEMENT MARKET OVERVIEW
5.2. GLOBAL KNEE CARTILAGE REPLACEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - BY TREATMENT MODALITY
6.1. OVERVIEW
6.2. TREATMENT MODALITY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. CELL BASED APPROACHES MARKET
6.3.1. Overview
6.3.2. Cell Based Approaches Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. CHONDROCYTE TRANSPLANTATION MARKET
6.3.3.1. Overview
6.3.3.2. Chondrocyte Transplantation Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. GROWTH FACTOR TECHNOLOGY MARKET
6.3.4.1. Overview
6.3.4.2. Growth Factor Technology Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. STEM CELLS MARKET
6.3.5.1. Overview
6.3.5.2. Stem Cells Market Revenue Forecasts and Analysis (US$ Mn)
6.4. NON-CELL BASED APPROACHES MARKET
6.4.1. Overview
6.4.2. Non-cell Based Approaches Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. TISSUE SCAFFOLDS MARKET
6.4.3.1. Overview
6.4.3.2. Tissue Scaffolds Market Revenue Forecasts and Analysis (US$ Mn)

6.4.4. CELL-FREE COMPOSITES MARKET
6.4.4.1. Overview
6.4.4.2. Cell-Free Composites Market Revenue Forecasts and Analysis (US$ Mn)

7. KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HYALINE CARTILAGE MARKET
7.3.1. Overview
7.3.2. Hyaline Cartilage Market Revenue Forecasts and Analysis (US$ Mn)
7.4. FIBROCARTILAGE MARKET
7.4.1. Overview
7.4.2. Fibrocartilage Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA KNEE CARTILAGE REPLACEMENT MARKET OVERVIEW
8.2. NORTH AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY TREATMENT MODALITY (US$ MN)
8.3.1. North America Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.3.2. North America Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4. NORTH AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
8.5. NORTH AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

8.6. US MARKET OVERVIEW
8.6.1. US Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
8.6.1.1. US Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.1.2. US Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2. US Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality (US$ Mn)
8.7.1.1. Canada Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.1.2. Canada Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2. Canada Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
8.8.1.1. Mexico Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.1.2. Mexico Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.2. Mexico Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)

9. EUROPE KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE KNEE CARTILAGE REPLACEMENT MARKET OVERVIEW
9.2. EUROPE KNEE CARTILAGE REPLACEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY TREATMENT MODALITY(US$ MN)
9.3.1. Europe Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. Europe Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. EUROPE KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. EUROPE KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
9.6.1.1. France Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.1.2. France Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2. France Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
9.7.1.1. Germany Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. Germany Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. Germany Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
9.8.1.1. UK Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. UK Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. UK Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)


10. ASIA PACIFIC KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC KNEE CARTILAGE REPLACEMENT MARKET OVERVIEW
10.2. ASIA PACIFIC KNEE CARTILAGE REPLACEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY TREATMENT MODALITY(US$ MN)
10.3.1. Asia Pacific Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Asia Pacific Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. ASIA PACIFIC KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. CHINA MARKET OVERVIEW
10.6.1. China Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
10.6.1.1. China Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.1.2. China Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2. China Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
10.7.1.1. India Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. India Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. India Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)

10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
10.8.1.1. Japan Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. Japan Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. Japan Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY TREATMENT MODALITY(US$ MN)
11.3.1. Middle East and Africa (MEA) Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3.2. Middle East and Africa (MEA) Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
11.6.1.1. South Africa Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. South Africa Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. South Africa Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)

11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
11.7.1.1. Saudi Arabia Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.1.2. Saudi Arabia Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.2. Saudi Arabia Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
11.8.1.1. UAE Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.1.2. UAE Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.2. UAE Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)

12. SOUTH AND CENTRAL AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA KNEE CARTILAGE REPLACEMENT MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY TREATMENT MODALITY(US$ MN)
12.3.1. South and Central America Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.3.2. South and Central America Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4. SOUTH AND CENTRAL AMERICA KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) KNEE CARTILAGE REPLACEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Treatment Modality(US$ Mn)
12.6.1.1. Brazil Cell-Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.1.2. Brazil Non-Cell Based Approaches Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.2. Brazil Knee Cartilage Replacement Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions
14. KNEE CARTILAGE REPLACEMENT MARKET, KEY COMPANY PROFILES
14.1. ANIKA THERAPEUTICS INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ZIMMER BIOMET
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BIOTISSUE
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. DEPUY SYNTHES
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GENZYME CORPORATION
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CELLGENIX GMBH
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. EMD SERONO INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SANOFI
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. OSIRIS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. TIGENIX NV
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. Anika Therapeutics
2. Zimmer Biomet
3. BioTissue
4. DePuy Synthes
5. Genzyme Corporation
6. CellGenix GmbH
7. EMD Serono Inc
8. Sanofi
9. Osiris
10. TiGenix